ACEi ARB Withdrawal in CKD Patients

Stopped Currently we are not pursuing this trial due t o limited bandwidth and have not enrolled any participants.

Conditions

• Chronic Kidney Disease
• Blood Pressure
• Angiotensin-converting Enzyme Inhibitor
• Angiotensin Receptor Blockers

Interventions

• OTHER: Continuation of ACEi and/or ARBs

Sponsor

University of California, San Francisco